SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001047469-98-045101
Filing Date
1998-12-24
Accepted
1998-12-24 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A SC 13D/A 15228
  Complete submission text file 0001047469-98-045101.txt   17216
Mailing Address
Business Address 215 COLLEGE RD PARAMUS NJ 07652 2012611331
SYNAPTIC PHARMACEUTICAL CORP (Subject) CIK: 0000884939 (see all company filings)

IRS No.: 222859704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45417 | Film No.: 98775783
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice